US 10508307
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
granted A61KA61K31/44A61P
Quick answer
US patent 10508307 (Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers) held by Transgenion—International Institute for Regenerative Translational Medicine GmbH expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Transgenion—International Institute for Regenerative Translational Medicine GmbH
- Grant date
- Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/44, A61P, A61P11/00